Rwanda Medical Journal
Rwanda Health Communication Center - Rwanda Biomedical Center (RHCC - RBC)
Vol. 77, No. 3, 2020, pp. 6-8
Bioline Code: rw20027
Full paper language: English
Document type: Case Report
Document available free of charge
Rwanda Medical Journal, Vol. 77, No. 3, 2020, pp. 6-8
© Copyright 2020 - The Author(s)
Capecitabine Induced Hand-Foot Syndrome—A Case Report|
Ndoli, D. A.; Manirakiza, A. & Rubagumya, F.
Hand and foot syndrome (HFS) is a dose limiting dermatological toxic reaction of some chemotherapy agents like Capecitabine.
Though not being life threatening, patient’s quality of life is compromised secondary to this syndrome. Early detection,
dose reduction and interruption of the causative agent have been found to be key in management of HFS. We report
a case of a 74-year-old female patient diagnosed with a metastatic rectal adenocarcinoma who received capecitabine as
her management, while on treatment she developed signs and symptoms consistent with HFS. The chemotherapy agent
was interrupted, and emollients were given to her as management.
Cancer; Capecitabine; Colorectal; 5-Fluorouracil; Hand-Food Syndrome; Chemotherapy; Side Effects
Alternative site location: http://www.rwandamedicaljournal.org